go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

New Hampshire rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$562,3410%20%10th90th$0Professionalmedian $562,341 · 10th–90th $562,341$616,5950%50%90th$562,341$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
Aetna
Setting
Professional
Modifier
Global
Typical Low
$478,630.09
Median
$562,341.33
Typical High
$676,082.98
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.03
Typical High
$0.05
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
Harvard Pilgrim
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$602,559.59
United
Setting
Facility
Modifier
Global
Typical Low
$933,254.30
Median
$933,254.30
Typical High
$933,254.30
United
Setting
Professional
Modifier
Global
Typical Low
$61,659.50
Median
$61,659.50
Typical High
$512,861.38
Well Sense
Setting
Facility
Modifier
Global
Typical Low
$478,630.09
Median
$537,031.80
Typical High
$588,843.66